Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-28
2010-10-12
Morris, Patricia L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S349000, C514S352000, C514S357000, C546S297000, C546S300000, C546S304000, C546S307000, C546S332000
Reexamination Certificate
active
07812037
ABSTRACT:
Compounds with antiplatelet aggregation and anticoagulant characteristics for the treatment of cardiovascular, cerebrovascular, and cardiovascular related diseases and symptoms, are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxine and/or substituted pyridoxine analogs.
REFERENCES:
patent: 3206463 (1965-09-01), Baetz
patent: 3227724 (1966-01-01), Firestone et al.
patent: 3282778 (1966-11-01), Lobel
patent: 3632806 (1972-01-01), Ichizo et al.
patent: 3910921 (1975-10-01), Esanu
patent: 3987177 (1976-10-01), Giudicelli et al.
patent: 4012377 (1977-03-01), Claisse et al.
patent: 4032534 (1977-06-01), Chodkiewicz
patent: 4036844 (1977-07-01), Thorne et al.
patent: 4053607 (1977-10-01), Thorne et al.
patent: 4137316 (1979-01-01), Esanu
patent: 4167562 (1979-09-01), Evers
patent: 4237118 (1980-12-01), Howard
patent: 4361570 (1982-11-01), Fici
patent: 4369172 (1983-01-01), Schor et al.
patent: 4374841 (1983-02-01), Descamps et al.
patent: 4515771 (1985-05-01), Fine
patent: 4567179 (1986-01-01), Lombardino
patent: 4569938 (1986-02-01), Esanu
patent: 4569939 (1986-02-01), Esanu
patent: 4581363 (1986-04-01), Esanu
patent: 4605741 (1986-08-01), Zagnoli et al.
patent: 4696920 (1987-09-01), Bentzen et al.
patent: 4730042 (1988-03-01), Hege et al.
patent: 4735950 (1988-04-01), Esanu
patent: 4735956 (1988-04-01), Baldwin et al.
patent: 4837239 (1989-06-01), Benjamin et al.
patent: 4843071 (1989-06-01), Hohenwarter
patent: 4898879 (1990-02-01), Madsen et al.
patent: 4962121 (1990-10-01), Hamberger et al.
patent: 5001115 (1991-03-01), Sloan
patent: 5053396 (1991-10-01), Blass
patent: 5118505 (1992-06-01), Költringer
patent: 5130311 (1992-07-01), Guillaumet et al.
patent: 5130324 (1992-07-01), Ulrich et al.
patent: 5132115 (1992-07-01), Wolter et al.
patent: 5155116 (1992-10-01), Guillaumet et al.
patent: 5210083 (1993-05-01), Pfirrmann
patent: 5213813 (1993-05-01), Kornecki et al.
patent: 5254557 (1993-10-01), Buckle et al.
patent: 5254572 (1993-10-01), Serfontein
patent: 5272165 (1993-12-01), Ulrich et al.
patent: 5278154 (1994-01-01), Lacoste et al.
patent: 5288716 (1994-02-01), Speck
patent: 5326757 (1994-07-01), Demopoulos
patent: 5328453 (1994-07-01), Sibalis
patent: 5372999 (1994-12-01), Schneider et al.
patent: 5385937 (1995-01-01), Stamler et al.
patent: 5420112 (1995-05-01), Lewis et al.
patent: 5441972 (1995-08-01), Ogata et al.
patent: 5504090 (1996-04-01), Neely
patent: 5563126 (1996-10-01), Allen et al.
patent: 5569459 (1996-10-01), Shlyankevich
patent: 5569648 (1996-10-01), Lewis et al.
patent: 5594004 (1997-01-01), Katano et al.
patent: 5631271 (1997-05-01), Serfontein
patent: 5633228 (1997-05-01), Lewis et al.
patent: 5648335 (1997-07-01), Lewis et al.
patent: 5728684 (1998-03-01), Cheng et al.
patent: 5733884 (1998-03-01), Barbul et al.
patent: 5733916 (1998-03-01), Neely
patent: 5770215 (1998-06-01), Moshyedi
patent: 5795873 (1998-08-01), Allen
patent: 5804163 (1998-09-01), Gibby et al.
patent: 5804594 (1998-09-01), Murad
patent: 5833998 (1998-11-01), Biedermann et al.
patent: 5834446 (1998-11-01), Dow et al.
patent: 5840685 (1998-11-01), Fujii et al.
patent: 5847008 (1998-12-01), Doebber et al.
patent: 5858017 (1999-01-01), Demopulos et al.
patent: 5859051 (1999-01-01), Adams et al.
patent: 5874420 (1999-02-01), Pelleg
patent: 5874443 (1999-02-01), Kiely et al.
patent: 5888514 (1999-03-01), Weisman
patent: 5944020 (1999-08-01), Markov et al.
patent: 6043259 (2000-03-01), Dhalla et al.
patent: 6051587 (2000-04-01), Dakashinamurti et al.
patent: 6066659 (2000-05-01), Speck
patent: 6121249 (2000-09-01), Weissman et al.
patent: 6274170 (2001-08-01), Heibel et al.
patent: 6323188 (2001-11-01), Weissman
patent: 6339085 (2002-01-01), Haque
patent: 6358960 (2002-03-01), Senokuchi et al.
patent: 6417204 (2002-07-01), Haque
patent: 6489345 (2002-12-01), Sethi
patent: 6544547 (2003-04-01), Hageman
patent: 6548519 (2003-04-01), Haque
patent: 6586414 (2003-07-01), Haque et al.
patent: 6605612 (2003-08-01), Haque
patent: 6667315 (2003-12-01), Haque
patent: 6677356 (2004-01-01), Sethi et al.
patent: 6780997 (2004-08-01), Haque
patent: 6861439 (2005-03-01), Haque et al.
patent: 6867215 (2005-03-01), Haque
patent: 6890943 (2005-05-01), Haque
patent: 6897228 (2005-05-01), Haque
patent: 7105673 (2006-09-01), Haque
patent: 7115625 (2006-10-01), Sethi et al.
patent: 7115626 (2006-10-01), Sethi et al.
patent: 7125889 (2006-10-01), Sethi et al.
patent: 7132430 (2006-11-01), Sethi et al.
patent: 7144892 (2006-12-01), Sethi et al.
patent: 7148233 (2006-12-01), Sethi et al.
patent: 7230009 (2007-06-01), Haque et al.
patent: 2003/0114424 (2003-06-01), Haque et al.
patent: 2004/0121988 (2004-06-01), Haque et al.
patent: 2004/0171588 (2004-09-01), Haque
patent: 2004/0186077 (2004-09-01), Diakur et al.
patent: 2004/0235907 (2004-11-01), Sethi
patent: 2005/0107443 (2005-05-01), Haque
patent: 2006/0019929 (2006-01-01), Friesen
patent: 2006/0035864 (2006-02-01), Friesen
patent: 2006/0094748 (2006-05-01), Haque et al.
patent: 2006/0094749 (2006-05-01), Haque et al.
patent: 2006/0148763 (2006-07-01), Friesen et al.
patent: 2006/0241083 (2006-10-01), Diakur et al.
patent: 2007/0032456 (2007-02-01), Friesen
patent: 2007/0060549 (2007-03-01), Friesen
patent: 2007/0142270 (2007-06-01), Haque et al.
patent: 2007/0149485 (2007-06-01), Friesen
patent: 2007/0167411 (2007-07-01), Reimer
patent: 2007/0243249 (2007-10-01), Friesen et al.
patent: 2007/0249562 (2007-10-01), Friesen
patent: 831350 (1976-01-01), None
patent: 863754 (1978-05-01), None
patent: 933 522 (1973-09-01), None
patent: 561 183 (1975-04-01), None
patent: 24 61 742 (1976-07-01), None
patent: 37 05 549 (1988-09-01), None
patent: 43 44 751 (1995-06-01), None
patent: 0 121 036 (1984-10-01), None
patent: 0 144 051 (1985-06-01), None
patent: 0 270 026 (1988-06-01), None
patent: 0 416 248 (1991-03-01), None
patent: 0 891 719 (1999-01-01), None
patent: 5552 (1967-12-01), None
patent: 5801 (1968-03-01), None
patent: 6453 (1968-12-01), None
patent: 2101010 (1972-03-01), None
patent: 2255883 (1975-07-01), None
patent: 2428640 (1980-01-01), None
patent: 1 013 939 (1965-12-01), None
patent: 1 201 014 (1970-08-01), None
patent: 1 248 324 (1972-02-01), None
patent: 1 297 080 (1972-11-01), None
patent: 1 360 536 (1974-07-01), None
patent: 1 493 993 (1977-12-01), None
patent: 1 597 428 (1981-09-01), None
patent: 2 254 556 (1992-10-01), None
patent: 48-21959 (1973-07-01), None
patent: 54-17130 (1979-02-01), None
patent: 10-158244 (1998-06-01), None
patent: 2000-26295 (2000-01-01), None
patent: WO 83/00085 (1983-01-01), None
patent: WO 91/19500 (1991-12-01), None
patent: WO 94/18965 (1994-09-01), None
patent: WO 97/30047 (1997-08-01), None
patent: WO 98/28310 (1998-07-01), None
patent: WO 02/34711 (2002-05-01), None
patent: WO 2005/060975 (2005-07-01), None
patent: WO 2005/070889 (2005-08-01), None
patent: WO 2006/005173 (2006-01-01), None
patent: WO 2006/026868 (2006-03-01), None
patent: WO 2006/056079 (2006-06-01), None
patent: WO 2006/058411 (2006-06-01), None
patent: WO 2006/102748 (2006-10-01), None
patent: WO 2006/136004 (2006-12-01), None
“B Vitamins May Cut Heart Disease Risk”,Harvard Health Letter, 1 page (1998).
Arbuzov, S., “Pharmacologocial Properties of the Products of the Condensation of Phenamine with Some Metabolites”,Farmakol. Toksikol, vol. 31, No. 3, pp. 373-376 (Abstract only) (1968).
Arbuzov., S., “Synthesis and Pharmacological Investigation of Some New Compounds Related Structurally to Some Natural Metabolites”,Conf. Hug. Ther. Invest. Pharmacol., Soc. Pharmacol. Hung., 489-502 (1966) (Abstract only).
Aybak, M. et al., “Effect of Oral Pyridoxine Hydrochloride Supplementation on Arterial Blood Pressure in Patients with Essential Hypertension”,Drug Res., vol. 45, No. 12, pp. 1271-1273 (1995).
Baliga, B. et al., “Hyperhomocysteinemia in Type 2 Diabetes Mellitus: Cardiovascular Risk Factors and Effect of Treatment with Folic Acid and Pyridoxine”,Endocrine Practice, vol. 6, No. 6, pp. 435-441 (Nov./Dec. 2000).
Ba
Diakur James
Haque Wasimul
Khan A. Qasim
Omar Mohammed
Pham Vinh
Dorn Brian R.
Medicure International Inc.
Merchant & Gould P.C.
Morris Patricia L
LandOfFree
Dual antiplatelet/anticoagulant pyridoxine analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dual antiplatelet/anticoagulant pyridoxine analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dual antiplatelet/anticoagulant pyridoxine analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4185708